Reason for request
Extension of indication
Clinical Benefit
Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years.
|
Clinical Added Value
no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes.
|
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
CsaeTBnyPJ2hdM3D